331 related articles for article (PubMed ID: 22398958)
21. Comparison of MR-less PiB SUVR quantification methods.
Bourgeat P; Villemagne VL; Dore V; Brown B; Macaulay SL; Martins R; Masters CL; Ames D; Ellis K; Rowe CC; Salvado O; Fripp J;
Neurobiol Aging; 2015 Jan; 36 Suppl 1():S159-66. PubMed ID: 25257985
[TBL] [Abstract][Full Text] [Related]
22. Cerebral microhemorrhage and brain β-amyloid in aging and Alzheimer disease.
Yates PA; Sirisriro R; Villemagne VL; Farquharson S; Masters CL; Rowe CC;
Neurology; 2011 Jul; 77(1):48-54. PubMed ID: 21700585
[TBL] [Abstract][Full Text] [Related]
23. Clinical Relevance of [
Librizzi D; Cabanel N; Zavorotnyy M; Riehl E; Kircher T; Luster M; Hooshyar Yousefi B
Molecules; 2021 Feb; 26(5):. PubMed ID: 33652938
[TBL] [Abstract][Full Text] [Related]
24. Biopathological Significance of Early-Phase Amyloid Imaging in the Spectrum of Alzheimer's Disease.
Bunai T; Kakimoto A; Yoshikawa E; Terada T; Ouchi Y
J Alzheimers Dis; 2019; 69(2):529-538. PubMed ID: 31104023
[TBL] [Abstract][Full Text] [Related]
25. Regional patterns of 18F-florbetaben uptake in presenilin 1 mutation carriers.
Sala-Llonch R; Falgàs N; Bosch B; Fernández-Villullas G; Balasa M; Antonell A; Perissinotti A; Pavía J; Campos F; Lladó A; Lomeña F; Sánchez-Valle R
Neurobiol Aging; 2019 Sep; 81():1-8. PubMed ID: 31207465
[TBL] [Abstract][Full Text] [Related]
26. PET quantification of 18F-florbetaben binding to β-amyloid deposits in human brains.
Becker GA; Ichise M; Barthel H; Luthardt J; Patt M; Seese A; Schultze-Mosgau M; Rohde B; Gertz HJ; Reininger C; Sabri O
J Nucl Med; 2013 May; 54(5):723-31. PubMed ID: 23471310
[TBL] [Abstract][Full Text] [Related]
27. Pittsburgh Compound B and AV-1451 positron emission tomography assessment of molecular pathologies of Alzheimer's disease in progressive supranuclear palsy.
Whitwell JL; Ahlskog JE; Tosakulwong N; Senjem ML; Spychalla AJ; Petersen RC; Jack CR; Lowe VJ; Josephs KA
Parkinsonism Relat Disord; 2018 Mar; 48():3-9. PubMed ID: 29254665
[TBL] [Abstract][Full Text] [Related]
28. A new Centiloid method for
Cho SH; Choe YS; Kim HJ; Jang H; Kim Y; Kim SE; Kim SJ; Kim JP; Jung YH; Kim BC; Baker SL; Lockhart SN; Na DL; Park S; Seo SW
Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1938-1948. PubMed ID: 31834446
[TBL] [Abstract][Full Text] [Related]
29. Biological characters of [18F]O-FEt-PIB in a rat model of Alzheimer's disease using micro-PET imaging.
Zheng MQ; Yin DZ; Zhang L; Lei B; Cheng DF; Cai HC; Han YJ; Wu MX; Zhang H; Wang J
Acta Pharmacol Sin; 2008 May; 29(5):548-54. PubMed ID: 18430362
[TBL] [Abstract][Full Text] [Related]
30. Longitudinal amyloid imaging using 11C-PiB: methodologic considerations.
van Berckel BN; Ossenkoppele R; Tolboom N; Yaqub M; Foster-Dingley JC; Windhorst AD; Scheltens P; Lammertsma AA; Boellaard R
J Nucl Med; 2013 Sep; 54(9):1570-6. PubMed ID: 23940304
[TBL] [Abstract][Full Text] [Related]
31. Use of T1-weighted/T2-weighted magnetic resonance ratio to elucidate changes due to amyloid β accumulation in cognitively normal subjects.
Yasuno F; Kazui H; Morita N; Kajimoto K; Ihara M; Taguchi A; Yamamoto A; Matsuoka K; Takahashi M; Nakagawara J; Iida H; Kishimoto T; Nagatsuka K
Neuroimage Clin; 2017; 13():209-214. PubMed ID: 28003959
[TBL] [Abstract][Full Text] [Related]
32. Imaging Biomarkers of Alzheimer Disease in Multiple Sclerosis.
Zeydan B; Lowe VJ; Reichard RR; Przybelski SA; Lesnick TG; Schwarz CG; Senjem ML; Gunter JL; Parisi JE; Machulda MM; Vemuri P; Mielke MM; Knopman DS; Petersen RC; Jack CR; Kantarci OH; Kantarci K
Ann Neurol; 2020 Apr; 87(4):556-567. PubMed ID: 31970802
[TBL] [Abstract][Full Text] [Related]
33. Standardized Expression of 18F-NAV4694 and 11C-PiB β-Amyloid PET Results with the Centiloid Scale.
Rowe CC; Jones G; Doré V; Pejoska S; Margison L; Mulligan RS; Chan JG; Young K; Villemagne VL
J Nucl Med; 2016 Aug; 57(8):1233-7. PubMed ID: 26912446
[TBL] [Abstract][Full Text] [Related]
34. Voxel-based analysis of 11C-PIB scans for diagnosing Alzheimer's disease.
Mikhno A; Devanand D; Pelton G; Cuasay K; Gunn R; Upton N; Lai RY; Libri V; Mann JJ; Parsey RV
J Nucl Med; 2008 Aug; 49(8):1262-9. PubMed ID: 18632806
[TBL] [Abstract][Full Text] [Related]
35. Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach.
Royse SK; Minhas DS; Lopresti BJ; Murphy A; Ward T; Koeppe RA; Bullich S; DeSanti S; Jagust WJ; Landau SM;
Alzheimers Res Ther; 2021 May; 13(1):99. PubMed ID: 33971965
[TBL] [Abstract][Full Text] [Related]
36. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
[TBL] [Abstract][Full Text] [Related]
37. Amyloid-β Deposition and Long-Term Progression in Mild Cognitive Impairment due to Alzheimer's Disease Defined with Amyloid PET Imaging.
Hatashita S; Wakebe D
J Alzheimers Dis; 2017; 57(3):765-773. PubMed ID: 28304292
[TBL] [Abstract][Full Text] [Related]
38. Correspondence between in vivo (11)C-PiB-PET amyloid imaging and postmortem, region-matched assessment of plaques.
Driscoll I; Troncoso JC; Rudow G; Sojkova J; Pletnikova O; Zhou Y; Kraut MA; Ferrucci L; Mathis CA; Klunk WE; O'Brien RJ; Davatzikos C; Wong DF; Resnick SM
Acta Neuropathol; 2012 Dec; 124(6):823-31. PubMed ID: 22864813
[TBL] [Abstract][Full Text] [Related]
39. Parametric imaging of dual-time window [
Heeman F; Yaqub M; Hendriks J; Bader I; Barkhof F; Gispert JD; van Berckel BNM; Lopes Alves I; Lammertsma AA
Neuroimage; 2021 Jul; 234():117953. PubMed ID: 33762215
[TBL] [Abstract][Full Text] [Related]
40. Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease.
Snellman A; López-Picón FR; Rokka J; Salmona M; Forloni G; Scheinin M; Solin O; Rinne JO; Haaparanta-Solin M
J Nucl Med; 2013 Aug; 54(8):1434-41. PubMed ID: 23833271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
